AstraZeneca signs LOI with IDT Biologika to boost Europe’s Covid-19 vaccine-making capability
Cambridge-based global, science-led biopharmaceutical company AstraZeneca and German manufacturer of viral vaccines and biologics IDT Biologika have signed a Letter of Intent (LOI) to increase Europe’s Covid-19 vaccine manufacturing capability.